Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

YO Clinical Case Discussion

Capmatinib in patient with astrocytoma grade 4 IDH mutation and MET exon 4 skipping mutation

Date

14 Mar 2024

Session

YO Clinical Case Discussion

Topics

Tumour Site

Central Nervous System Malignancies

Presenters

David Dufek

Authors

D. Dufek

Author affiliations

  • Department Of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, 656 53 - Brno/CZ

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.